Literature DB >> 8239588

Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies.

G Klopman1, S Wang, M R Jacobs, J J Ellner.   

Abstract

The structures and inhibitory activities of 88 quinolones, previously studied as potential in vitro inhibitors of 14 selected strains of Mycobacterium avium complex, were examined in an effort to identify a quinolone with optimal activity towards all strains. A MULTICASE structure-activity relationship analysis of the inhibitory activities of these 88 quinolones against 14 strains of M. avium was performed and led to the identification of a number of structural constraints required to overcome the resistance of most of the strains. Our data suggested that the increased resistance of the strains was probably not due to a specific resistance mechanism but rather due to gradual limitation of the constraints imposed on the structure of the quinolones. This increasing structural selectivity could be produced either at the level of cell membrane penetration or at the level of interaction with the DNA gyrase receptor site. On the basis of these findings, a number of new quinolones holding the promise of superior activity are currently being evaluated in vitro and in vivo to determine the clinical relevance of our observations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239588      PMCID: PMC188074          DOI: 10.1128/AAC.37.9.1807

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Computer automated structure evaluation of quinolone antibacterial agents.

Authors:  G Klopman; O T Macina; M E Levinson; H S Rosenkranz
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

2.  Anti-Mycobacterium avium activity of quinolones: in vitro activities.

Authors:  G Klopman; S Wang; M R Jacobs; S Bajaksouzian; K Edmonds; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.

Authors:  J M Domagala; L D Hanna; C L Heifetz; M P Hutt; T F Mich; J P Sanchez; M Solomon
Journal:  J Med Chem       Date:  1986-03       Impact factor: 7.446

4.  Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.

Authors:  H Koga; A Itoh; S Murayama; S Suzue; T Irikura
Journal:  J Med Chem       Date:  1980-12       Impact factor: 7.446

5.  Structure-activity relationships among DNA gyrase inhibitors. Synthesis and biological evaluation of 1,2-dihydro-4, 4-dimethyl-1-oxo-2-naphthalenecarboxylic acids as 1-carba bioisosteres of oxolinic acid.

Authors:  T Högberg; I Khanna; S D Drake; L A Mitscher; L L Shen
Journal:  J Med Chem       Date:  1984-03       Impact factor: 7.446

  5 in total
  7 in total

1.  Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.

Authors:  R Gozalbes; M Brun-Pascaud; R García-Domenech; J Gálvez; P M Girard; J P Doucet; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Anti-Mycobacterium avium activity of quinolones: in vitro activities.

Authors:  G Klopman; S Wang; M R Jacobs; S Bajaksouzian; K Edmonds; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  Antimycobacterial activities of novel levofloxacin analogues.

Authors:  K Kawakami; K Namba; M Tanaka; N Matsuhashi; K Sato; M Takemura
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

4.  N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.

Authors:  G Klopman; D Fercu; T E Renau; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions.

Authors:  P S Skinner; S K Furney; M R Jacobs; G Klopman; J J Ellner; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

Review 6.  Activity of quinolones against mycobacteria.

Authors:  M R Jacobs
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations.

Authors:  G Klopman; J Y Li; S Wang; A J Pearson; K Chang; M R Jacobs; S Bajaksouzian; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.